Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NYSE:CLX
NYSE:CLXHousehold Products

Clorox Brings Purell Into Portfolio What The Deal Could Mean For Investors

Clorox (NYSE:CLX) has completed its acquisition of GOJO Industries, the company behind the Purell brand. The deal brings Purell hand sanitizer and related hygiene solutions into Clorox's global portfolio. This move expands Clorox's presence in health and hygiene products beyond its existing cleaning and disinfecting lineup. Clorox is widely known for cleaning and disinfecting products used in homes, workplaces, and healthcare settings, and Purell is a familiar name in hand hygiene across...
NYSE:SNDR
NYSE:SNDRTransportation

A Look At Schneider National (SNDR) Valuation After Recent 19% Share Price Move

Schneider National (SNDR) has been drawing attention after its share price moved roughly 19% over the past month, prompting investors to reassess how the US$5.0b transportation and logistics company is currently being valued. See our latest analysis for Schneider National. That recent 19.3% 1 month share price return comes after a quieter few months, with the 90 day share price return at roughly flat and a 1 year total shareholder return of 28.8% suggesting momentum has been stronger over the...
ASX:MGH
ASX:MGHConstruction

A Look At MAAS Group Holdings (ASX:MGH) Valuation As On‑Market Buy‑Backs Continue

MAAS Group Holdings (ASX:MGH) has been actively running its on market share buy back, regularly repurchasing ordinary shares. For you as an investor, that kind of capital management puts the spotlight on per share outcomes. See our latest analysis for MAAS Group Holdings. MGH’s recent buy back activity comes as the share price trades at A$4.30, with a 1 day share price return of 2.38% and a 7 day share price return of 6.97%. This is set against a 30 day share price return of a 14.85% decline...
ENXTBR:ARGX
ENXTBR:ARGXBiotechs

Why argenx (ENXTBR:ARGX) Is Up 5.4% After Completing Its Key CIDP Switch Study

Recently, argenx reported the completion of a key CIDP switch study for its efgartigimod therapy, marking a meaningful clinical milestone in its autoimmune portfolio. This progress in CIDP strengthens the case for efgartigimod as a potentially broader platform therapy across neuromuscular autoimmune indications. Next, we will examine how completion of the CIDP switch study might influence argenx’s investment narrative and outlook for efgartigimod. Capitalize on the AI infrastructure...
NasdaqGM:ACMR
NasdaqGM:ACMRSemiconductor

Is ACM Research’s (ACMR) ‘Planetary’ Rebrand a Branding Lift or a Strategy Shift?

In early April 2026, ACM Research, Inc. reorganized and rebranded its semiconductor equipment portfolio into the ACM Planetary Family, grouping tools into eight process-based “planet” series spanning cleaning, advanced packaging, electroplating, furnace, track, PECVD, panel-level packaging, and polishing applications. This clearer, process-aligned structure may help customers map ACM’s expanding lineup to specific manufacturing steps, potentially reinforcing the company’s role across...
NYSE:CLH
NYSE:CLHCommercial Services

Clean Harbors (CLH) Valuation Check After Citi Upgrade And PFAS Growth Expectations

Citi’s upgrade of Clean Harbors (CLH) to Buy, tied to anticipated growth in U.S. chemicals production and rising demand for hazardous waste disposal, has become a key catalyst that is drawing fresh attention to the stock. See our latest analysis for Clean Harbors. The share price has climbed to $302.23, with a 30-day share price return of 4.60% and a 90-day share price return of 18.25%. The 1-year total shareholder return of 50.89% points to strong momentum supported by Citi’s upgrade and...
TASE:NXSN
TASE:NXSNElectronic

A Look At NextVision Stabilized Systems (TASE:NXSN) Valuation After New US$5.5m Camera Order

NextVision Stabilized Systems (TASE:NXSN) is in focus after announcing a new US$5.5 million order for its stabilized cameras and accessories from an unrelated customer, with 15% already paid and delivery planned by late third quarter 2026. See our latest analysis for NextVision Stabilized Systems. Despite the new US$5.5 million order supporting the business story, the share price has been volatile, with a 30 day share price return of a 15.4% decline contrasting with a 33.5% year to date gain...
NYSE:TFIN
NYSE:TFINBanks

Did Trump’s Brief Iran Strike Pause and Softer Oil Prices Just Shift Triumph Financial’s (TFIN) Investment Narrative?

In early April 2026, President Trump announced a two-week suspension of attacks on Iran, easing geopolitical tensions and contributing to lower crude oil prices and a more stable backdrop for global financial markets. This temporary reduction in geopolitical risk supported a more favorable operating climate for banks like Triumph Financial, as investors reassessed credit risk and the outlook for lending activity in a less volatile energy and geopolitical setting. We’ll now explore how this...
TSE:8194
TSE:8194Consumer Retailing

Assessing Life Corporation (TSE:8194) Valuation After Solid 2026 Results And Dividend Update

Why Life (TSE:8194) is Back on Dividend Watch After Its Latest Results Life (TSE:8194) just paired solid full year 2026 results with a board meeting that focused on surplus dividends and dividend forecasts, a combination that naturally draws attention from income focused investors. See our latest analysis for Life. After the latest earnings and dividend news, Life’s share price has climbed, with a 6.79% 1 month share price return and a 30.82% 1 year total shareholder return. If this mix of...
XTRA:DUE
XTRA:DUEMachinery

A Look At Dürr (XTRA:DUE) Valuation After Announcing A €0.80 Annual Dividend

Dividend announcement and what it means for investors Dürr (XTRA:DUE) has announced an annual dividend of €0.80 per share, payable on May 27, 2026, with an ex dividend date of May 25 and record date of May 26. See our latest analysis for Dürr. The dividend announcement comes after a mixed period for investors, with a 12.1% 1 month share price return and an 11.9% 7 day share price return contrasting with a 7.9% 3 month share price decline and a 5.9% year to date share price decline. Over the...
NYSE:HGV
NYSE:HGVHospitality

Assessing Hilton Grand Vacations (HGV) Valuation After Recent Share Price Swings

Why Hilton Grand Vacations Is On Investors’ Radar Hilton Grand Vacations (HGV) has stayed in focus after recent share price moves, with the stock closing at US$44.92 and showing mixed returns over the past week, month, and past 3 months. For investors tracking timeshare and resort operators, HGV’s US$4.5b revenue base and US$81 million net income highlight a sizeable, diversified business spanning real estate sales, financing, and resort operations across the United States, Japan, and...
NYSE:FCN
NYSE:FCNProfessional Services

A Look At FTI Consulting (FCN) Valuation After Recent Share Price Volatility

Event context and recent share performance FTI Consulting (FCN) has come onto investor radars after recent share price moves, with the stock closing at US$176.26 and showing mixed short term performance, including a 2.6% decline over the past day. See our latest analysis for FTI Consulting. While the 1 day share price return of negative 2.6% and 7 day share price return of negative 3.9% point to some fading short term momentum, the 30 day share price return of 8.4% alongside a 1 year total...
NasdaqGS:ARCB
NasdaqGS:ARCBTransportation

Is ArcBest’s (ARCB) Award-Winning Security Masking Deeper Strains in Its Profitability Story?

In recent years, ArcBest has faced softer customer demand, with purchases postponed and revenue declining by 4.8% annually over the past two years, while earnings per share fell even faster. At the same time, ABF Freight’s twelfth American Trucking Associations’ Excellence in Security Award signals operational strengths that contrast with ArcBest’s weakening returns on capital. We’ll now examine how ArcBest’s declining profitability and returns on capital may reshape the company’s broader...
NasdaqGM:KYMR
NasdaqGM:KYMRBiotechs

How Investors Are Reacting To Kymera Therapeutics (KYMR) Gilead Option Exercise And US$45M Milestone

On 9 April 2026, Kymera Therapeutics announced that Gilead Sciences exercised its option to exclusively license KT-200, a first-in-class oral CDK2 molecular glue degrader, triggering a US$45,000,000 milestone payment and moving the program into IND-enabling studies targeting an IND filing in 2027. This option exercise means Kymera has now received US$85,000,000 of up to US$750,000,000 in potential collaboration payments, plus prospective tiered royalties on any future KT-200 product...
NasdaqGS:WING
NasdaqGS:WINGHospitality

Wingstop (WING) Is Up 18.0% After Buyback Boost And Upgrades Shift Sentiment On Self-Help Initiatives

In early April 2026, Wingstop launched a limited-time Citrus Mojo wing flavor and exclusive Sprite Loco Lime beverages across its U.S. restaurants, while also expanding its footprint with new locations such as a planned Converse, Texas opening this winter. At the same time, a cluster of analyst upgrades and a US$300 million expansion of Wingstop’s share repurchase authorization has shifted sentiment around the brand’s self-help and digital initiatives after a period of weaker same-store...
OB:DNB
OB:DNBBanks

Assessing DNB (OB:DNB) Valuation After Barclays Upgrade And Conflicting Fair Value Signals

Barclays has upgraded DNB Bank (OB:DNB) to overweight, pointing to valuation and earnings prospects even as competitive pressures persist. For you as an investor, the move raises fresh questions about how DNB compares with other Nordic banks. See our latest analysis for DNB Bank. Recent trading supports Barclays’ stance, with a 6.05% 1 month share price return and 11.17% 3 month share price return. The 1 year total shareholder return of 31.83% and 3 year total shareholder return of 91.82%...
NYSE:HLX
NYSE:HLXEnergy Services

A Look At Helix Energy Solutions (HLX) Valuation After Recent Share Price Momentum

Key recent performance context for Helix Energy Solutions Group Helix Energy Solutions Group (HLX) has drawn attention after a period where the share price showed an 8.4% gain over the past month and a 37.0% return over the past 3 months. See our latest analysis for Helix Energy Solutions Group. The recent 30 day share price return of 8.4% builds on a 37.0% gain over 3 months. This sits within a wider pattern where the year to date share price return is 49.4% and the 1 year total shareholder...
NasdaqGS:BPOP
NasdaqGS:BPOPBanks

A Look At Popular (BPOP) Valuation After Earnings Beat Streak And New Leadership Changes

Popular (BPOP) is back in focus after a cluster of recent updates, including fresh leadership appointments, ongoing preferred dividends, and close attention on its upcoming earnings release and its recent record of topping estimates. See our latest analysis for Popular. Recent leadership changes and attention on earnings coincide with share price momentum, with a 7 day share price return of 5.85% and year to date share price return of 14.97%, while the 1 year total shareholder return stands...
ENXTPA:BVI
ENXTPA:BVIProfessional Services

Bureau Veritas (ENXTPA:BVI) Valuation After Launch Of EU AI Act Compliance Audit Service

Bureau Veritas (ENXTPA:BVI) has launched an AI systems audit designed to help European enterprises assess compliance with the EU AI Act, using AWS AI Risk Intelligence to shorten assessments and produce standardized AI maturity reports. See our latest analysis for Bureau Veritas. Recent announcements around AI compliance services and trade finance partnerships come as the share price sits at €27.21, with a 7 day share price return of 2.99% but a 30 day share price return decline of 3.44%. The...
NYSE:AME
NYSE:AMEElectrical

AMETEK (AME) Is Up 7.6% After Record Backlog And Innovation Push - Has The Bull Case Changed?

In early April 2026, AMETEK reported a record backlog of US$3.58 billion, highlighted that recent innovations now drive about one-third of its revenue growth, issued guidance for mid-to-high single-digit sales growth in 2026, and earmarked US$100 million for targeted growth initiatives alongside a strong mergers and acquisitions pipeline. This combination of a very large order book, a 30% vitality index, and planned investment and acquisition activity underscores how management is...
NYSE:FDS
NYSE:FDSCapital Markets

Assessing FactSet Research Systems (FDS) Valuation After A Steep Year To Date Share Price Decline

Why FactSet Research Systems (FDS) Is on Investors’ Radar FactSet Research Systems (FDS) is drawing attention after recent trading left the stock with a year-to-date total return of about a 26% decline and a 1-year total return near a 50% decline. Those moves come against a backdrop of annual revenue of roughly US$2.4 billion and net income of about US$587.8 million, giving investors concrete fundamentals to weigh against the share price performance. See our latest analysis for FactSet...
NasdaqGS:MTSI
NasdaqGS:MTSISemiconductor

Do Insider Sales Undercut Analyst Optimism on MACOM (MTSI) and Its Next-Gen Connectivity Story?

Earlier this week, Loop Capital initiated coverage on MACOM Technology Solutions Holdings, highlighting its exposure to high-growth end markets such as AI-focused data centers and satellite communications across civil, defense, and telecom infrastructure. At the same time, significant insider share sales over recent months contrast with upbeat analyst views, offering investors a revealing split between internal behavior and external optimism about MACOM’s role in next-generation...
NYSE:NPKI
NYSE:NPKITrade Distributors

Does Strong Q4 Beat and Governance Focus Change The Bull Case For NPK International (NPKI)?

NPK International recently reported fourth-quarter 2025 results that exceeded both revenue and earnings forecasts, while CFO Gregg Piontek sold 15,000 shares under a pre-arranged Rule 10b5-1 plan and Dimensional Fund Advisors disclosed a 4.7% beneficial interest. The company is also asking shareholders to vote at its May 20, 2026 annual meeting on director elections, executive pay, and auditor ratification, underscoring its focus on governance practices such as majority voting, independent...
NasdaqGM:OCUL
NasdaqGM:OCULPharmaceuticals

How Axpaxli Phase 3 Anticipation from Key Ophthalmology Meetings Will Impact Ocular Therapeutix (OCUL) Investors

Ocular Therapeutix recently highlighted its retinal pipeline at major ophthalmology meetings, where senior leaders discussed managing neovascular age-related macular degeneration and the role of tyrosine kinase inhibitors in treating diabetic retinal disease. Investors are closely watching these conference appearances for fresh colour on the phase 3 Axpaxli program, which sits at the centre of the company’s long-term growth plans. We’ll now explore how anticipated Axpaxli phase 3 updates...